Product Information
- ((2,4,6-Tris(1-Methylethyl)Phenyl)Acetyl)Sulfamicacid2,6-Bis(1-Methylethyl)Phenylester
- 2,6-Di(Propan-2-Yl)Phenyl {[2,4,6-Tri(Propan-2-Yl)Phenyl]Acetyl}Sulfamate
- 2,6-Diisopropylphenyl (2-(2,4,6-triisopropylphenyl)acetyl)sulfamate
- Avasimin
- Ci 1011
- N-(2,6-Dipropan-2-Ylphenoxy)Sulfonyl-2-(2,4,6-Tripropan-2-Ylphenyl)Acetamide
- N-[(2,6-Diisopropylphenoxy)Sulfonyl]-2-(2,4,6-Triisopropylphenyl)Acetamide
- Pd 148515
- Sulfamic acid, N-[2-[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 2,6-bis(1-methylethyl)phenyl ester
- Sulfamic acid, [[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 2,6-bis(1-methylethyl)phenyl ester
- See more synonyms
Avasimibe is a drug that inhibits the enzyme DPP-IV and prevents the degradation of DPP-IV substrates, such as peptides, proteins, and lipids. It also has other pharmacological effects such as inhibiting the mitochondrial membrane potential and inducing cell lysis. Avasimibe is used to treat atherosclerosis by preventing cholesterol from being absorbed by cells. It is also used in cancer treatment for its ability to inhibit viral life and reduce tumor size. In addition, avasimibe is able to inhibit BCR-ABL kinase activity and induce apoptosis in human leukemia cells.
Chemical properties
Technical inquiry about: 3D-RGA51860 Avasimibe
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.